Open Access & Peer-Reviewed

International Journal of Vasculitis - Instructions for Authors

Modern, submission-ready guidance for efficient review and clinical impact

Quick Compliance Panel

Title page with affiliations, ORCID, funding, and contributions
Structured abstract with objectives, methods, results, conclusions
Ethics approval and consent statements included
Clinical trial registration number in abstract and methods
IMRAD structure and continuous line numbering
Figures at 300 dpi and fully de-identified
Editable tables with clear titles and units
Data availability statement with access terms
Vancouver references with DOI links where possible
Cover letter confirming exclusivity and preprint disclosure

Author Preparation Blueprint

Start with a clean, submission-ready manuscript. This blueprint highlights the essentials editors check first so your paper moves smoothly into peer review.

Submission Readiness

Title page with authorship, affiliations, ORCID, funding, and contributions
Structured abstract with clear objectives, methods, results, and conclusion
Ethics approval and consent statements included
Trial registration and protocol references where required
Figures at 300 dpi and fully de-identified
Editable tables with clear titles, units, and legends
Data availability statement with repository or access terms
Cover letter confirming exclusivity and preprint disclosure

Formatting Snapshot

Item	Requirement
File format	Word (.doc or .docx)
Font	12 pt, double spaced
Line numbers	Continuous
References	Vancouver with DOI

This guide helps authors prepare manuscripts for the International Journal of Vasculitis. Clear structure improves review speed and supports high-impact publication.

We publish original research, reviews, brief reports, methods, and editorials across vasculitis diagnosis, pathophysiology, and treatment.

Use ManuscriptZone or the simple submission form and choose the workflow that best fits your team.

Align with reporting frameworks such as CONSORT, STROBE, PRISMA, CARE, ARRIVE, or STARD when appropriate and submit any required checklists.

Include ethics approvals, informed consent statements, and trial registration numbers where required.

Describe study design, setting, patient population, and endpoints clearly to strengthen reproducibility and clinical impact.

If you are unsure about scope or study type, contact the editorial office before submission for guidance.

Provide clear definitions for disease classifications and diagnostic criteria used in the study.

Include adverse event reporting and safety monitoring details for interventional studies.

Define inclusion and exclusion criteria clearly for cohort and trial studies.

Specify diagnostic criteria used for vasculitis classification and disease activity scoring.

Include adverse event definitions and safety monitoring procedures for interventions.

Describe imaging modalities and acquisition parameters for vascular studies.

Report follow up duration and relapse definitions where applicable.

Provide clear descriptions of laboratory assays and biomarker thresholds.

Use consistent terminology for disease subtypes across all sections.

Confirm that all coauthors approve the final submission before upload.

Include a data availability statement that aligns with ethics approvals and consent.

Ensure that tables and figures match the narrative and are cited in order.

Provide funding acknowledgments and sponsor roles in the title page or acknowledgments.

Describe statistical handling of missing data and sensitivity analyses.

State whether a study protocol was registered and provide registry details.

Clarify any deviations from registered protocols in the methods section.

If using patient images, confirm explicit consent for publication.

Use standardized abbreviations and define them at first use.

Include a short running title and corresponding author contact details.

Describe the setting and care context for clinical studies.

Manuscripts should use standard IMRAD structure unless article type requires a different format.

Abstracts should be structured and include background, methods, results, and conclusion with key numbers.

Provide 3 to 6 keywords using MeSH terms when possible.

Tables must be editable and submitted as text, not embedded images.

Figures should be high resolution with a minimum of 300 dpi.

Use SI units and report laboratory values with reference ranges when relevant.

State sample size justification or power calculations for interventional studies.

Clinical trial reports must include CONSORT flow diagrams.

Observational studies should align with STROBE guidance.

Systematic reviews must include PRISMA flow and search strategy details.

For animal studies, follow ARRIVE guidance and describe welfare monitoring.

Include a limitations paragraph addressing bias and generalizability.

Provide acknowledgments for statistical or medical writing assistance.

Supplementary material should be labeled clearly and referenced in the main text.

Limitations should note confounders, missing data, and diagnostic uncertainty where relevant.

Provide a structured data availability statement even when data are fully open.

Include ethics committee name and approval number in the methods section.

Use descriptive figure captions that stand alone without the main text.

Ensure abbreviations in tables are defined in footnotes.

Check references for DOI accuracy and consistent formatting.

Upload a cover letter summarizing novelty and clinical relevance.

Quality Signals We Look For

Clinical Relevance

Explain how findings improve diagnosis, treatment decisions, or patient outcomes.

Method Transparency

Provide protocols, inclusion criteria, and statistical plans for reproducibility.

Ethics and Data

Include approvals, consent, and responsible data access plans.

Reporting Clarity

Ensure consistency across text, tables, and figures for efficient review.

Manuscript Preparation Standards

Title Page

Accountability

Establish authorship, funding transparency, and ethical accountability to avoid screening delays.

Full author names, affiliations, and ORCID identifiers
Corresponding author email and address
Funding sources and grant numbers
Conflict of interest and author contribution statements
Ethics approval identifiers and consent statements

Abstract

Discoverability

Use a structured abstract to help readers and indexers understand clinical relevance.

Objective, Methods, Results, Conclusion
Study design, population, and primary outcomes
Key numeric findings or effect sizes
Trial registration number when relevant

Main Text

Clinical Rigor

Provide enough detail for replication with clear methodology and statistical reporting.

Define study design, setting, and participant selection
Describe interventions, comparators, and outcomes
Report statistical methods and software versions
Discuss limitations and clinical implications

Formatting Snapshot

Item	Requirement
File format	Word (.doc or .docx)
Font and spacing	12 pt, double spaced
Line numbers	Continuous
Trial registration	Registry ID included

Figures and Tables

Clarity

Figures and tables should communicate results clearly and respect patient confidentiality.

Images at 300 dpi in TIFF, JPEG, or PNG
Remove patient identifiers from images
Include scale bars, labels, and abbreviations
Upload tables as editable files with units

Formatting Snapshot

Element	Standard
Resolution	300 dpi minimum
Color mode	RGB
Legends	Complete and standalone
Tables	Editable and titled

References

Citation Integrity

Accurate references speed production and improve discoverability.

Vancouver style references
Include DOI links where available
Cite trial registrations and datasets
Check for accuracy before submission

Supplementary Materials

Transparency

Supplementary files strengthen transparency and support reproducibility.

Supplementary tables and figures cited in order
Protocols or checklists for clinical trials
Analytic code or statistical scripts when possible
Data dictionaries and variable definitions

Ethics and Consent

Provide IRB or ethics committee approvals and informed consent statements for human or animal studies.

Data Availability

State where de-identified data are stored, include access criteria, and describe any embargoes.

Trial Registration

Clinical trials must be registered prior to enrollment. Include registry name and ID.

Submission Workflow

Step 1

Prepare Core Files

Assemble title page, manuscript, figures, tables, and supplementary files.

Step 2

Run Compliance Check

Confirm ethics approvals, trial registration, and data availability.

Step 3

Submit Online

Upload through ManuscriptZone or the Simple Submission Form.

Step 4

Respond to Review

Provide point-by-point responses and revised manuscripts.

Step 5

Proof and Publish

Review page proofs and confirm final metadata.

Recommended Reporting Guidelines

CONSORT STROBE PRISMA CARE ARRIVE STARD CHEERS TREND

Revision and Production Guidance

Respond to reviewers with a point-by-point letter and highlight changes in the revised manuscript.

Ensure terminology is consistent across abstract, methods, results, and tables.

Proofs should be checked carefully for author names, affiliations, and data accuracy.

Post-publication corrections are handled transparently to protect the scholarly record.

Author FAQs

Do you accept preprints?

Yes. Disclose preprint posting at submission and update records after acceptance.

Are data availability statements mandatory?

Yes. Every manuscript must include a clear data availability statement.

What file formats are accepted for figures?

Submit figures at 300 dpi in TIFF, JPEG, or PNG formats.

Can I suggest reviewers?

Yes. Provide suggested reviewers with relevant expertise and no conflicts.

Do you require ORCID identifiers?

ORCID is strongly recommended for all authors.

What are the typical word counts?

Original research is typically 4,000 to 8,000 words, reviews 6,000 to 10,000 words.

Submit Your Manuscript

Use the submission portals above to start your International Journal of Vasculitis review process.

Need help? Contact us at [email protected]